Aralia Racemosa Mt Liquid
NDC Package 66096-751-08

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Aralia Racemosa Mt (aralia racemosa) liquids is a human prescription drug administered via oral route. This formulation utilizes a liquid delivery system. Marketed by Ohm Pharma Inc., this product is identified by NDC 66096-751.

Identification & Billing

NDC Package Code
66096-751-08
Package Description
.25 L in 1 BOTTLE
Product Code
11-Digit Billing Format
66096075108

Clinical Specifications

Proprietary Name
Aralia Racemosa Mt
Non-Proprietary Name
Aralia Racemosa
Substance Name
Aralia Racemosa Root
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Ohm Pharma Inc.
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
03-01-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66096-751-08 identifies a specific commercial package of .25 l in 1 bottle of Aralia Racemosa Mt, a human prescription drug labeled by Ohm Pharma Inc.. This liquid is formulated for oral use and contains aralia racemosa root as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ohm Pharma Inc. on March 01, 2019. The current certification is valid through December 31, 2026.

How is this Ohm Pharma Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66096075108. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66096-751-08
11-Digit CMS (5-4-2)
66096-0751-08

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.